Document:

exv10w1

Exhibit 10.1

NON-EXECUTIVE CHAIRMAN SERVICE AGREEMENT

This Non-Executive Chairman Service Agreement (this “Agreement”), is dated as of March 11,
2011 and is entered into between Endurance Specialty Holdings Ltd. (the “Company”), and William H.
Bolinder (the “Chairman”).

WHEREAS, the Chairman has served as a director of the Company since its inception and as Lead
Director of the Company since 2006;

WHEREAS, the Board of Directors (the “Board”) has elected the Chairman to become the
Non-Executive Chairman of the Board of the Company; and

WHEREAS, the Company and the Chairman desire to enter into this Agreement in order to embody
the terms of the Chairman’s service as Non-Executive Chairman of the Board;

NOW, THEREFORE, in consideration of the premises and the mutual agreements contained herein,
the Company and the Chairman hereby agree as follows:

ARTICLE I.

Service as Non-Executive Chairman

1.1 Term of Service. The term of service of the Chairman as the Company’s
non-executive chairman of the Board commenced on March 3, 2011 and shall continue until the
earliest of (a) the date of the Company’s 2014 Annual General Meeting of Shareholders, (b) the date
of the Chairman’s death, (c) the Chairman’s resignation from the position of chairman of the Board,
(d) the failure to re-elect the Chairman as a member of the Board, or (e) the removal of the
Chairman from the position of Chairman of the Board (the “Term”). The Chairman hereby agrees to
serve as the non-executive chairman of the Board upon the terms and subject to the conditions
contained in this Agreement during the Term.

1.2 Duties and Responsibilities. The Chairman shall have such duties and
responsibilities that are customary for a non-executive chairman of the board, including but not
limited to attendance at Board and committee meetings and participation on Board update telephone
conferences. The Chairman’s performance of any duties and responsibilities shall be conducted in a
manner consistent with any tax operating guidelines promulgated from time to time by the Board.

1.3 Independent Director. It is intended that the Chairman continue as an
“independent director” in accordance with the Company’s Corporate Governance Guidelines, the
applicable provisions of the Securities Exchange Act of 1934 (and the rules promulgated
thereunder), and the listing standards of the New York Stock Exchange, each as they may from time
to time be amended. In the event that any term of this Agreement causes the Chairman to cease to
be considered an “independent director” as so defined, the Chairman and the Company agree to amend
such term in order to permit the Chairman to continue to be an “independent director” as so
defined.

 

 

ARTICLE II.

Compensation and Expenses

2.1 Board Compensation, Incentive Compensation and Benefits. As compensation and
consideration for the performance by the Chairman of his obligations as a non-executive chairman of
the Board under this Agreement, the Chairman shall be entitled, during the Term, to the following
(subject, in each case, to the provisions of Article III hereof):

(a) Board and Committee Fees. The Chairman shall be entitled to receive any
fees paid generally from time to time to non-executive members of the Board for service on
the Board and for acting as chairman of any committees thereof, at the time and in the
amounts applicable to other non-executive members of the Board.

(b) Incentive Compensation. The Chairman shall be eligible to receive any
incentive compensation delivered generally from time to time to non-executive members of the
Board for service on the Board and for acting as chairman of any committees thereof in the
accordance with the terms and conditions applicable to such payments for other non-executive
members of the Board.

(c) Chairman Fee. In addition to any fees and incentive compensation payable
pursuant to Sections 2.1(a) and 2.1(b), the Chairman shall be entitled to receive a
supplementary fee of $160,000 per annum commencing on March 3, 2011 and continuing for the
duration of the Term, prorated for any partial year served (the “Supplementary Fee”). One
half ($80,000) of the Supplementary Fee shall be paid in cash on a quarterly basis ($20,000
per quarter) in accordance with the Company’s customary payment practices with respect to
non-executive members of the Board. The remaining half ($80,000) of the Supplementary Fee
shall be delivered in the form of restricted shares (the “Restricted Shares”) granted on the
date of the Annual General Meeting of Shareholders of the Company, with the first such grant
being on March 11, 2011 and the last such grant being on the date of the 2013 Annual General
Meeting of Shareholders (provided that the Term of the Agreement has not ended, in
accordance with Section 1.1 of the Agreement, prior to such date). The Restricted Shares
granted under this Section 2.1(c) shall be granted under and subject to the terms of the
Company’s 2007 Equity Incentive Plan, as amended from time to time (the “Equity Incentive
Plan”). The number of Restricted Shares granted shall be determined by dividing $80,000 by
the Fair Market Value (as defined in the Equity Incentive Plan) of an ordinary share, par
value $1.00 per share, of the Company on the date of grant, rounded downward to the nearest
whole number of Restricted Shares. The Restricted Shares shall vest on the first annual
anniversary of the date of grant, subject to the continued service of the Chairman as a
non-executive member of the Board through the vesting date. Each grant of the Restricted
Shares shall be evidenced by a written agreement, the terms of which shall be consistent
with the terms of restricted share grants to non-executive members of the Board generally,
subject to adjustment by the Compensation Committee of the Board in order to comply with
applicable law and custom and practice. In the event that the Company is unable to deliver
the Restricted Shares due to the failure of the Company’s shareholders to approve at the
2011 Annual General Meeting of Shareholders the amendment to the Company’s 2007 Equity Incentive Plan necessary to permit the
delivery of the Restricted Shares in the manner contemplated by this Section 2.1(c), in lieu
of the Restricted Shares the Company shall deliver the remaining half of the Supplementary
Fee in cash on the date of each Annual General Meeting of Shareholders when Restricted
Shares would otherwise have been delivered.

 

-2-

 

(d) Expense Reimbursement. The Company will reimburse the Chairman for
reasonable expenses incurred by the Chairman in connection with the performance of the
Chairman’s duties hereunder during the Term in accordance with the Company’s policies
relating to the reimbursement of expenses of non-executive members of the Board as in effect
from time to time. Prior to such payment the Chairman shall provide to the Company any
written substantiation for such expenses requested by the Company.

(e) Benefits. The Chairman shall be eligible to participate in any benefits
offered to non-executive members of the Board generally, as may be maintained from time to
time during the Term. The Chairman shall not be eligible to participate in any savings
plan, pension plan, life insurance, health insurance, disability insurance, major medical
insurance benefits or such other employee benefit plans or programs for the benefit of the
employees or officers of the Company generally.

2.2 Tax Withholding. The Chairman is responsible for paying all federal, state, and
local income or business taxes, including estimated taxes, self-employment and any other taxes,
fees, additions to tax, interest or penalties which may be assessed, imposed, or incurred as a
result of any compensation paid by the Company to the Chairman pursuant to this Agreement.

2.3 Indemnification/Liability Insurance. The Company shall indemnify the Chairman as
required by the Bye-laws of the Company, and may maintain customary insurance policies providing
for indemnification of the Chairman. In addition to the foregoing, the Chairman and the Company
agree that this Agreement shall not supersede the Indemnification Agreement, dated November 20,
2008 (the ‘Indemnification Agreement”), between the Company and the Chairman, which shall remain in
full force and effect.

ARTICLE III.

Termination of Agreement

3.1 Termination of Agreement. This Agreement shall terminate and be of no further
force or effect upon the completion of the Term.

(a) In the event the Chairman’s service as a non-executive member of the Board
continues following completion of the Term, (i) with respect to periods of service following
the completion of the Term, the Chairman shall be entitled to receive all fees, incentive
compensation, expense reimbursement and benefits available to non-executive members of the
Board generally from time to time, (ii) within 15 calendar days following the expiration of
the Term, the Chairman shall be entitled to receive any accrued but unpaid portion of the
cash component of the Supplementary Fee, prorated for any partial year of service as the
non-executive chairman of the Board elapsing prior to the expiration of the Term, (iii)
Restricted Shares previously granted pursuant to this Agreement shall continue to vest based on the Chairman’s service as a non-executive
member of the Board following the expiration of the Term and (iv) the Chairman shall
continue to be entitled to the benefits of the Indemnification Agreement. The Chairman
shall not be entitled to the grant of any Restricted Shares pursuant to this Agreement
following the completion of the Term (including, for the avoidance of doubt, any Restricted
Shares relating to any partial years of service provided between any prior grant of
Restricted Shares and the completion of the Term).

 

-3-

 

(b) In the event the Chairman’s service as a non-executive member of the Board does not
continue following completion of the Term, (i) with respect to periods of service following
the completion of the Term, the Chairman shall be entitled to receive all fees, incentive
compensation, expense reimbursement and benefits available to non-executive members of the
Board generally from time to time, (ii) within 15 calendar days following the expiration of
the Term, the Chairman shall be entitled to receive any accrued but unpaid portion of the
cash component of the Supplementary Fee, prorated for any partial year of service as the
non-executive chairman of the Board elapsing prior to the expiration of the Term, and (iii)
the Chairman shall continue to be entitled to the benefits of the Indemnification Agreement.
The Chairman shall not be entitled to the grant of any Restricted Shares pursuant to this
Agreement following the completion of the Term (including, for the avoidance of doubt, any
Restricted Shares relating to any partial years of service provided between any prior grant
of Restricted Shares and the completion of the Term) and any Restricted Shares granted
pursuant to this Agreement that are unvested as of the completion of the Term shall be
forfeited.

ARTICLE IV.

Miscellaneous

4.2 Benefit of Agreement; Assignment; Beneficiary. This Agreement shall inure to the
benefit of and be binding upon the Company and its successors and assigns, including, without
limitation, any corporation or person which may acquire all or substantially all of the Company’s
assets or business, or with or into which the Company may be consolidated or merged. This
Agreement shall also inure to the benefit of, and be enforceable by, the Chairman and his personal
or legal representatives, executors, administrators, successors, heirs, distributes, devisees and
legatees. The Company shall require any successor (whether direct or indirect, by operation of
law, purchase, merger, consolidation or otherwise) to all or substantially all of the business
and/or assets of the Company to expressly assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform it if no such
succession had taken place.

 

-4-

 

4.3 Notices. All notices and other communications required or permitted hereunder
shall be in writing and shall be deemed given when (a) delivered personally or by overnight courier
to the following address of the other party hereto (or such other address for such party as shall
be specified by notice given pursuant to this Section 4.3) or (b) sent by facsimile to the
following facsimile number of the other party hereto (or such other facsimile number for such party
as shall be specified by notice given pursuant to this Section 4.3), with the confirmatory copy
delivered by overnight courier to the address of such party pursuant to this Section 4.3:

If to the Company, to:

Endurance Specialty Holdings Ltd.

Wellesley House

90 Pitts Bay Road

Pembroke HM 08, Bermuda

Attention: General Counsel

Facsimile: (441) 278-0401

If to the Chairman, to the residence address or residence facsimile number of the Chairman set
forth in the records of the Company.

4.4 Entire Agreement: This Agreement contains the entire agreement of the parties
hereto with respect to the terms and conditions of the Chairman’s employment and supersedes any and
all prior agreements and understandings, whether written or oral, between the parties hereto with
respect to the subject matter hereof; provided, that, the Indemnification Agreement shall remain in
full force and effect.

4.5 Amendment and Waiver. This Agreement may not be changed or modified except by an
instrument in writing signed by both of the parties hereto. The waiver by either party of a breach
of any provision of this Agreement shall not operate or be construed as a continuing waiver or as a
consent to or waiver of any subsequent breach hereof.

4.6 Headings. The Article and Section headings herein are for convenience of
reference only, do not constitute a part of this Agreement and shall not be deemed to limit or
affect any of the provisions hereof.

4.7 Arbitration. Any dispute or controversy between the Company and the Chairman,
whether arising out of or relating to this Agreement, the breach of this Agreement, or otherwise,
shall be settled by arbitration in Hamilton, Bermuda administered in accordance with the
Arbitration Act 1986, and judgment on the award rendered by the arbitrator may be entered in any
court having jurisdiction thereof. The arbitrator shall have the authority to award any remedy or
relief that a court of competent jurisdiction could order or grant, including, without limitation,
the issuance of an injunction. However, either party may, without inconsistency with this
arbitration provision, apply to any court having jurisdiction over such dispute or controversy and
seek interim provisional, injunctive or other equitable relief until the arbitration award is
rendered or the controversy is otherwise resolved. Except as necessary in court proceedings to
enforce this arbitration provision or an award rendered hereunder, or to obtain interim relief,
neither a party nor an arbitrator may disclose the existence, content or results of any arbitration
hereunder without the prior written consent of the Company and the Chairman. The Chairman shall
have no right to enforce any of his rights hereunder by seeking or obtaining injunctive or other
equitable relief and acknowledges that damages are an adequate remedy for any breach by the Company
of this Agreement.

4.8 Governing Law. This Agreement shall be governed by, and construed and interpreted
in accordance with, the internal laws of Bermuda, without regard to principles of conflict of laws.

 

-5-

 

4.9 Compliance with Section 409A. This Agreement is intended to comply with Section
409A of the Internal Revenue Code of 1986, as amended and shall be construed and interpreted in
accordance with such intent.

4.10 Severability. Whenever possible, each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision
of this Agreement is held to be invalid, illegal or unenforceable in any respect under applicable
law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect
the validity, legality or enforceability of any other provision of this Agreement or the validity,
legality or enforceability of such provision in any other jurisdiction, but this Agreement shall be
reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable
provision had never been contained herein.

4.11 Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall be deemed to be an original but all of which together will constitute one and the
same instrument.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	 	ENDURANCE SPECIALTY HOLDINGS LTD.

 	 
	 	By:  	/s/ John V. Del Col
 	 
	 	 	Name:  	John V. Del Col 	 
	 	 	Title:  	General Counsel 	 
	 
	 	/s/ William H. Bolinder
 	 
	 	William H. Bolinder 	 

 

-6-EX-10.1

Exhibit 10.1

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (“Agreement”) is entered into effective as of March 8, 2011 (the
“Effective Date”), by and among Streamline Health Solutions, Inc., a Delaware corporation (the
“Parent”) and Streamline Health, Inc., an Ohio corporation (the “Company”) and Rick Leach
(“Executive”).

RECITALS:

The Parent, the Company and Executive hereby agree that Executive shall serve as Senior Vice
President & Chief Marketing Officer of the Parent and of the Company pursuant to the terms and
conditions set forth in this Agreement;

NOW, THEREFORE, in consideration of the premises and the agreements contained herein, and for
other good and valuable consideration, the receipt and adequacy of which the parties hereby
acknowledge, the parties agree as follows:

1. EMPLOYMENT

The Parent and the Company hereby agrees to employ Executive, and Executive, in consideration
of such employment and other consideration set forth herein, hereby accepts employment, upon the
terms and conditions set forth herein.

2. POSITION AND DUTIES

During the term of this Agreement, Executive shall be employed as the Senior Vice President &
Chief Marketing Officer for the Company and will also serve as an officer of the Parent for no
additional compensation, as part of Executive’s services to the Company hereunder. While employed
hereunder, Executive shall do all things necessary, legal and incident to the above position, and
otherwise shall perform such executive vice president-level functions, as the CEO of the Company
may establish from time to time.

3. COMPENSATION

Subject to such modifications as may be contemplated by said exhibit and approved from time to
time by the Parent’s Board of Directors or the Compensation Committee of such Board, Executive
shall receive the compensation and benefits listed on the attached Exhibit A. Such compensation and
benefits shall be paid and provided by the Company in accordance with the Company’s regular
payroll, compensation and benefits policies.

 

 

 

4. EXPENSES

The Company shall pay or reimburse Executive for all travel and out-of-pocket expenses
reasonably incurred or paid by Executive in connection with the performance of Executive’s duties
as an employee of the Company upon compliance with the Company’s procedures for expense
reimbursement, including the presentation of expense statements or receipts or such other
supporting documentation as the Company may reasonably require.

5. PRIOR EMPLOYMENT; BINDING AGREEMENT

Executive warrants and represents to the Parent and the Company (i) that Executive will take
no action in violation of any employment agreement or arrangement with any prior employer, (ii)
that Executive has disclosed to the Parent and the Company all such prior written agreements, (iii)
that any employment agreement or arrangement with any prior employer is null and void and of no
effect, and (iv) that Executive has the full right and authority to enter into this Agreement and
to perform all of Executive’s obligations hereunder. The Executive agrees to indemnify and hold the
Parent and the Company harmless from and against any and all claims, liabilities or expenses
incurred by the Parent and/or the Company as a result of any claim made by any prior employer
arising out of this Agreement or the employment of Executive by the Parent and the Company. The
Parent and the Company warrant and represent to the Executive that the Parent and the Company,
acting by the officer executing this Agreement on their behalf, has the full right and authority
to enter into this Agreement and to perform all of the Parent’s and the Company’s obligations
hereunder.

6. OUTSIDE EMPLOYMENT

Executive shall devote Executive’s full time and attention to the performance of the duties
incident to Executive’s position with the Parent and the Company, and shall not have any other
employment with any other enterprise or substantial responsibility for any enterprise which would
be inconsistent with Executive’s duty to devote Executive’s full time and attention to the Parent’s
and the Company’s matters; provided, however, that, the foregoing shall not prevent Executive from
participation in any charitable or civic organization or from service in a non-executive capacity
on the boards of directors of up to two other companies that does not interfere with Executive’s
performance of the duties and responsibilities to be performed by Executive under this Agreement.

7. CONFIDENTIAL INFORMATION

Executive shall not, during the term of this Agreement or at any time thereafter, disclose, or
cause to be disclosed, in any way Confidential Information, or any part thereof, to any person,
firm, corporation, association, or any other operation or entity, or use the Confidential
Information on Executive’s own behalf, for any reason or purpose. Executive further agrees that,
during the term of this Agreement or at any time thereafter, Executive will not distribute, or
cause to be distributed, Confidential Information to any third person or permit the reproduction of
Confidential Information, except on behalf of the Parent or the Company in Executive’s capacity as
an officer of the Parent or as an employee of the Company. Executive shall take all reasonable care
to avoid unauthorized disclosure or use of the Confidential Information.
Executive hereby assumes
responsibility for and shall indemnify and hold the Parent and the Company harmless from and
against any disclosure or use of the Confidential Information in violation of this Agreement.

 

 

 

For the purpose of this Agreement, “Confidential Information” shall mean any written or
unwritten information which specifically relates to and or is used in the Parent’s and/or the
Company’s business (including, without limitation, the Parent’s and/or the Company’s services,
processes, patents, systems, equipment, creations, designs, formats, programming, discoveries,
inventions, improvements, computer programs, data kept on computer, engineering, research,
development, applications, financial information, information regarding services and products in
development, market information including test marketing or localized marketing, other information
regarding processes or plans in development, trade secrets, training manuals, know-
how of the Parent and/or the Company, and the customers, clients, suppliers and others with
whom the Parent and/or the Company does or has in the past done, business, regardless of when and
by whom such information was developed or acquired) which the Parent or the Company deems
confidential and proprietary which is generally not known to others outside the Parent or the
Company and which gives or tends to give the Parent or the Company a competitive advantage over
persons who do not possess such information or the secrecy of which is otherwise of value to the
Parent and/or the Company in the conduct of its business — regardless of when and by whom such
information was developed or acquired, and regardless of whether any of these are described in
writing, reduced to practice, copyrightable or considered copyrightable, patentable or considered
patentable. Provided, however, that “Confidential Information” shall not include general industry
information or information which is publicly available or is otherwise in the public domain without
breach of this Agreement, information which Executive has lawfully acquired from a source other
than the Parent or the Company, or information which is required to be disclosed pursuant to any
law, regulation, or rule of any governmental body or authority or court order. Executive
acknowledges that Confidential Information is novel, proprietary to and of considerable value to
the Parent and the Company.

Executive agrees that all restrictions contained in this Section 7 are reasonable and valid
under the circumstances and hereby waives all defenses to the strict enforcement thereof by the
Parent and/or the Company.

Executive agrees that, upon the request of the Parent or the Company, or immediately on
termination of his employment for whatever reason, Executive will immediately deliver up to the
requesting entity all Confidential Information in Executive’s possession and/or control, and all
notes, records, memoranda, correspondence, files and other papers, and all copies, relating to or
containing Confidential Information. Executive does not have, nor can Executive acquire, any
property or other right in Confidential Information.

8. PROPERTY OF THE PARENT AND THE COMPANY

All ideas, inventions, discoveries, proprietary information, know-how, processes and other
developments and, more specifically improvements to existing inventions, conceived by Executive,
alone or with others, during the term of Executive’s employment, whether or not during working
hours and whether or not while working on a specific project, that are within the scope of the
Parent’s or the Company’s business operations or that relate to any work or projects

 

 

 

of the Parent
or the Company, are and shall remain the exclusive property of the Parent and the Company.
Inventions, improvements and discoveries relating to the business of the Parent or the Company
conceived or made by Executive, either alone or with others, while an officer of the Parent or
while employed with the Company are conclusively and irrefutably presumed to have been made during
the period of employment and are the sole property of the Parent and the Company. The Executive
shall promptly disclose in writing any such matters to the Parent and the Company but to no other
person without the consent of the Company. Executive hereby assigns and agrees to assign all right,
title, and interest in and to such matters to the Company. Executive will, upon request of the
Company, execute such assignments or other instruments and assist the Parent and the Company in the
obtaining, at the Company’s sole expense, of any patents, trademarks or similar protection, if
available, in the name of the Company.

9. NON-COMPETITION AGREEMENT

(a) During the term of Executive’s employment, whether under this Agreement or at will, and
for a period of two years after the termination date of Executive’s employment (whether such
termination be with or without cause), Executive agrees, provided he has received all the
compensation specified in Sections 11 and 13 hereof to be received by him coincident with such
termination, that he will not directly or indirectly, whether as an employee, agent, consultant,
director, officer, investor, partner, shareholder, proprietor, lender or otherwise own, operate or
otherwise work for or participate in any competitive business (including the pertinent division or
subsidiary of any multi-sector business), anywhere in the world, which designs, develops,
manufactures or markets any product or service that in any way competes with the Parent’s or the
Company’s business, products or services as conducted, or planned to be conducted, on the date of
termination (a “Competitive Business”), provided that the foregoing shall not prohibit Executive
from owning not more than 5% of the outstanding stock of a corporation subject to the reporting
requirements of the Securities Exchange Act of 1934.

(b) During the term of Executive’s employment and for a period ending two years from the
termination of Executive’s employment with the Company, whether by reason of the expiration of the
term of this Agreement, resignation, discharge by the Parent and the Company or otherwise,
Executive hereby agrees that Executive will not, directly or indirectly:

(i) solicit, otherwise attempt to employ or contract with any current or future employee of
the Parent or the Company for employment or otherwise in any Competitive Business or otherwise
offer any inducement to any current or future employee of the Parent or the Company to leave the
Parent’s or the Company’s employ; or

(ii) contact or solicit any customer or client of the Parent or the Company (an “Existing
Customer”), contact or solicit any individual or business entity with whom the Parent or the
Company has directly communicated for the purpose of rendering services prior to the effective date
of such termination (a “Potential Customer”), or otherwise provide any other products or services
for any Existing Customer or Potential Customer of the Parent or the Company, on behalf of a
Competitive Business or in a manner that is competitive to the Parent’s or the Company’s business;
or

 

 

 

(iii) Use or divulge to anyone any information about the identity of the
Parent’s or the
Company’s customers or suppliers (including without limitation, mental or written customer lists
and customer prospect lists), or information about customer requirements, transactions, work
orders, pricing policies, plans, or any other Confidential Information.

(c) For the purpose of this Agreement, Competitive Business shall mean any business operation
(including a sole proprietorship) anywhere in the world which designs, develops, manufactures or
markets any product or service that in any way competes with the Parent’s or the Company’s
healthcare document management software and document workflow software business, products or
services as conducted, or contemplated to be conducted, on the date of termination.

10. TERM

Unless earlier terminated pursuant to Section 11 hereof, the term of this Agreement (the
“Term”) shall be for the time period beginning on the Effective Date, and continuing through March
8, 2012 (the “Expiration Date”). On the Expiration Date, and on each annual Expiration
Date thereafter (each such date being hereinafter referred to as the “Renewal Date”), absent
notice to the contrary from either party hereto to the other received at least 60 days prior to
commencement of the Renewal Term, the term of employment hereunder shall automatically renew for an
additional one (1) year period. Unless waived in writing by the Company, the requirements of
Sections 7 (Confidential Agreement), 8 (Property of the Parent and the Company) and 9
(Non-Competition Agreement) shall survive the expiration or termination of this Agreement for any
reason.

11. TERMINATION.

(a) Death. This Agreement and Executive’s employment hereunder shall be terminated on the
death of Executive, effective as of the date of Executive’s death.

(b) Continued Disability. This Agreement and Executive’s employment hereunder may be
terminated, at the option of the Company, upon a Continued Disability of Executive, effective as of
the date of the determination of Continued Disability as that term is hereinafter defined. For the
purposes of this Agreement, “Continued Disability” shall be defined as the inability or incapacity
(either mental or physical) of Executive to continue to perform Executive’s duties hereunder for a
continuous period of one hundred twenty (120) working days, or if, during any calendar year of the
Term hereof because of disability, Executive shall have been unable to perform Executive’s duties
hereunder for a total period of one hundred eighty (180) working days regardless of whether or not
such days are consecutive. The determination as to whether Executive is unable to perform the
essential functions of Executive’s job shall be made by the CEO in his reasonable discretion;
provided, however, that if Executive is not satisfied with the decision of the CEO, Executive will
submit to examination by three competent physicians who practice in the metropolitan area in which
the Company then resides, one of whom shall be selected by the Company, another of whom shall be
selected by Executive, with the third to be selected by the physicians so selected. The
determination of a majority of the physicians so selected shall supersede the determination of the
Board and shall be final and conclusive.

 

 

 

(c) Termination For Good Cause. Notwithstanding any other provision of this Agreement, the
Company may at any time immediately terminate this Agreement and Executive’s employment thereunder
for Good Cause. For this purpose, “Good Cause” shall include the following: the current use of
illegal drugs; conviction of any crime which involves moral turpitude, fraud or misrepresentation;
commission of any act which would constitute a felony and which adversely impacts the business or
reputation of the Company; fraud; misappropriation or embezzlement of Parent or Company funds or
property; willful misconduct or grossly negligent or reckless conduct which is materially injurious
to the reputation, business or business relationships of the Parent or the Company; material
violation or default on any of the provisions of this Agreement; or material and continuous failure
to meet reasonable performance criteria or reasonable standards of conduct as established from time
to time by the CEO, which failure continues for at least 30 days after written notice from the
Company to Executive. Any alleged cause for termination shall be delivered in writing to Executive
stating the full basis for such cause along with any notice of such termination.

(d) Termination Without Good Cause. The Company may terminate Executive’s employment and all
other positions prior to the Expiration Date at any time, whether or not for Good Cause (as “Good
Cause” is defined in Section 11(c) above). In the event the
Company terminates Executive prior to the Expiration Date, for reasons other than Good Cause,
Executive’s Death, or Executive’s Disability, the Company will pay Executive a lump sum amount
equal to fifty (50) percent of Executive’s annual base salary as in effect as of the date of such
separation from employment, plus an amount equal to fifty (50) percent of the higher of the bonus
and commissions paid to Executive during that prior fiscal year or earned in the then current
fiscal year to date (provided that if Executive is terminated without Good Cause during the first
twelve months of employment with the Company, the bonus and commission component of the separation
payment will be equal to fifty (50) percent of the Target Bonus and Commission specified in Exhibit
A for the period), which shall be paid as soon as practicable following Executive’s execution (and
non-revocation) of a form of general release of claims as is acceptable to the Board. In any
event, the Company shall provide such release to Executive in a timely manner so that after the
longest available review and revocation period, the lump sum severance shall be paid no later than
the 90th day following Executive’s separation from service.

12. ADVICE TO PROSPECTIVE EMPLOYERS

If Executive seeks or is offered employment by any other company, firm or person, he will
notify the prospective employer of the existence and terms of the non-competition and
confidentiality agreements set forth in Sections 7 and 9 of this Agreement.

13. CHANGE IN CONTROL; ACCELERATED VESTING SCHEDULES

(a) In the event that, within twelve months of a change in control of the Parent, Executive’s
employment by the Company is terminated prior to the end of the then current Term or Executive
terminates his employment due to a material reduction in his duties or compensation (“Good
Reason”), all stock options and restricted stock granted to Executive shall immediately vest in
full, and the Company will pay Executive a lump sum amount in accordance with Section 11(d), above.
In the event Executive seeks to terminate his employment for Good Reason, such termination shall
not be treated for purposes of this Section 13 as a resignation for

 

 

 

Good Reason unless Executive
provides the Company with notice of the existence of the condition claimed to constitute Good
Reason within 90 days of the initial existence of such condition and the Company fails to remedy
such condition within 30 days following the Company’s receipt of such notice.

(b) For purposes of this Agreement, “change in control” means any of the following events:

(i) A change in control of the direction and administration of the Parent’s business of a
nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation
14A promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”), as in
effect on the date hereof and any successor provision of the regulations under the 1934 Act,
whether or not the Parent is then subject to such reporting requirements; or

(ii) Any “person” (as such term is used in section 13(d) and section 14(d)(2) of the 1934 Act
but excluding any employee benefit plan of the Parent) is or becomes the “beneficial owner” (as
defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of securities of the Parent
representing more than one half of the combined voting power of the
Parent’s outstanding securities then entitled to vote for the election of directors; or

(iii) The Parent shall sell all or substantially all of the assets of the Parent; or

(iv) The Parent shall participate in a merger, reorganization, consolidation or similar
business combination that constitutes a change in control as defined in the Parent’s 2005 Incentive
Compensation Plan and/or results in the occurrence of any event described in Sections 13(b) (i),
(ii) or (iii) above.

(c) Notwithstanding anything to the contrary contained in this Agreement, in the event any
amounts payable hereunder would be considered to be excess parachute payments for purposes of the
amount payable following the occurrence of a Change of Control that is treated as a “change in the
ownership or effective control” of the Parent or “in the ownership of a substantial portion of the
assets” of the Parent for purposes of Sections 280G and 4999 of the Internal Revenue Code of 1986,
as amended (the “Code”), those payments that are treated for purposes of Code Section 280G as being
contingent on a “change in the ownership or effective control” (as that phrase is used for purposes
of Code Section 280G) of the Parent shall be reduced, if and to the extent necessary, so that no
payments under this Agreement are treated as excess parachute payments.

14. ACKNOWLEDGEMENTS

The Parent, the Company and Executive each hereby acknowledge and agree as follows:

(a) The covenants, restrictions, agreements and obligations set forth herein are founded upon
valuable consideration, and, with respect to the covenants, restrictions, agreements and
obligations set forth in Sections 7, 8 and 9 hereof, are reasonable in duration and geographic
scope;

 

 

 

(b) In the event of a breach or threatened breach by Executive of any of the covenants,
restrictions, agreements and obligations set forth in Section 7, 8 and/or 9, monetary damages or
the other remedies at law that may be available to the Parent and/or the Company for such breach or
threatened breach will be inadequate and, without prejudice to the Parent’s or the Company’s right
to pursue any other remedies at law or in equity available to it for such breach or threatened
breach, including, without limitation, the recovery of damages from Executive, the Parent and/or
the Company will be entitled to injunctive relief from a court of competent jurisdiction; and

(c) The time period and geographical area set forth in Section 9 hereof are each divisible and
separable, and, in the event that the covenants not to compete contained therein are judicially
held invalid or unenforceable as to such time period and/or geographical area, they will be valid
and enforceable in such geographical area(s) and for such time period(s) which the court determines
to be reasonable and enforceable. Executive agrees that in the event any court of competent
jurisdiction determines that the above covenants are invalid or unenforceable to join with the
Parent and the Company in requesting that court to construe the applicable provision by limiting or
reducing it so as to be enforceable to the extent compatible with the then applicable law.
Furthermore, any period of restriction or covenant herein stated shall not include any period of
violation or period of time required for litigation to enforce such
restriction or covenant.

15. NOTICES

Any notice or communication required or permitted hereunder shall be given in writing and
shall be sufficiently given if delivered personally or sent by telecopy to such party addressed as
follows:

(a) In the case of the Parent or the Company, if addressed to it as follows:

Streamline Health, Inc.

10200 Alliance Road, Suite 200

Cincinnati, Ohio 45242-4716

Attn: Chief Financial Officer

(b) In the case of Executive, if addressed to Executive at the most recent address on file
with the Company.

Any such notice delivered personally or by telecopy shall be deemed to have been received on
the date of such delivery. Any address for the giving of notice hereunder may be changed by notice
in writing.

 

 

 

16. ASSIGNMENT, SUCCESSORS AND ASSIGNS

This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective legal representatives, successors and assigns. The Parent and the Company may assign or
otherwise transfer its rights under this Agreement to any successor or affiliated business or
corporation (whether by sale of stock, merger, consolidation, sale of assets or otherwise), but
this Agreement may not be assigned, nor may the duties hereunder be delegated by Executive. In the
event that the Parent and the Company assign or otherwise transfer their rights under this
Agreement to any successor or affiliated business or corporation (whether by sale of stock, merger,
consolidation, sale of assets or otherwise), for all purposes of this Agreement, the “Parent” and
the “Company” shall then be deemed to include the successor or affiliated business or corporation
to which the Parent and the Company, respectively, assigned or otherwise transferred their rights
hereunder.

17. MODIFICATION

This Agreement may not be released, discharged, abandoned, changed, or modified in any manner,
except by an instrument in writing signed by each of the parties hereto.

18. SEVERABILITY

The invalidity or unenforceability of any particular provision of this Agreement shall not
affect any other provisions hereof and the parties shall use their best efforts to substitute a
valid, legal and enforceable provision, which, insofar as practical, implements the purpose of this
Agreement. Any failure to enforce any provision of this Agreement shall not constitute a waiver
thereof or of any other provision hereof.

19. COUNTERPARTS

This Agreement may be signed in counterparts (and delivered via facsimile transmission), and
each of such counterparts shall constitute an original document and such counterparts, taken
together, shall constitute one in the same instrument.

20. ENTIRE AGREEMENT

This constitutes the entire agreement among the parties with respect to the subject matter of
this Agreement and supersedes all prior and contemporaneous agreements, understandings, and
negotiations, whether written or oral, with respect to such subject matter.

21. DISPUTE RESOLUTION

Except as set forth in Section 14 above, any and all disputes arising out of or in connection
with the execution, interpretation, performance, or non-performance of this Agreement or any
agreement or other instrument between, involving or affecting the parties (including the validity,
scope and enforceability of this arbitration clause), shall be submitted to and resolved by
arbitration. The arbitration shall be conducted pursuant to the terms of the Federal Arbitration
Act and the Employment Arbitration Rules and Mediation Procedures of the American Arbitration
Association. Either party may notify the other party at any time of the existence of an arbitrable
controversy by certified mail and the parties shall attempt in good faith to resolve their
differences within fifteen (15) days after the receipt of such notice. If the dispute cannot be
resolved within the fifteen-day period, either party may file a written demand for arbitration with
the American Arbitration Association. The place of arbitration shall be Cincinnati, Ohio.

 

 

 

22. SECTION 409A

If Executive is a “specified employee” under Section 409A of the Internal Revenue Code of
1986, as amended (“Code”), amounts that are deferred compensation are not payable to the Executive
until six months after his date of termination. If Section 409A applies, then notwithstanding the
preceding sentence and as an exception to the six-month delay otherwise required by Section 409A of
the Code, amounts due under Section 11(D) will be payable in regular installments in accordance
with the Company’s general payroll practices for salaried employees until the March 15th of the
year following the year of termination with the regular installment payment that immediately
precedes March 15 to include any installment amounts that would otherwise be delayed because of the
six-month delay. After the expiration of the six-month delay period following the date of
termination, any and all remaining amounts due to Executive will then be paid to Executive in a
lump sum.

Executive’s termination of employment occurs on or prior to the March 15th of the year
following the year of the change in control, the lump sum due to Executive pursuant to Section 13
will be paid immediately (but not later than the applicable March 15th) following the date of
termination. But if Executive is a “specified employee” under Section 409A of the Code and
Executive’s termination of employment occurs later than the March 15th of the year following the
year of the change in control, the lump sum will be immediately payable after the expiration of six
months after the date of such termination of employment.

If any tax is imposed on Executive under Section 409A of the Code with respect to any payment
made by the Company to Executive pursuant to Section 11(D) or Section 13, Executive will be
responsible for payment of such tax, penalty, interest and any related audit costs incurred by
Executive.

23. GOVERNING LAW

The provisions of this Agreement shall be governed by and interpreted in accordance with the
laws of the State of Ohio and the laws of the United States applicable therein. The Executive
acknowledges and agrees that Executive is subject to personal jurisdiction in state and federal
courts in Hamilton County, Ohio.

IN WITNESS WHEREOF, this Agreement has been executed by the parties hereto effective as of the
date first above written.

	 	 	 	 	 
	 	STREAMLINE HEALTH SOLUTIONS, INC.

 	 
	 	By:  	/s/ ROBERT E. WATSON
 	 
	 	 	Robert E. Watson 	 
	 	 	CEO 	 

 

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	STREAMLINE HEALTH, INC.

 	 
	 	By:  	/s/ ROBERT E. WATSON
 	 
	 	 	Robert E. Watson 	 
	 	 	CEO 	 
	 
	 	EXECUTIVE

 	 
	 	/s/ R. D. Leach
 	 
	 	Rick Leach 	 
	 	 	 

 

 

 

	 	 	 	 	 

EXHIBIT A — COMPENSATION AND BENEFITS

	1.	 	Start Date. Executive’s start date shall be March 14, 2011.
	 
	2.	 	Base Salary. Base Salary shall be paid at an annualized rate of $180,000, which shall be
subject to periodic review and adjustment by Compensation Committee (the “Committee”) of the
Board of the Parent.
	 
	2.	 	Bonus & Commissions. Target Bonus and Commissions and target goals shall be set by the CEO
annually, subject to approval by the Committee. Initial target Bonus and Commission (for FY
commencing 2/1/11) will be $50,000 and $70,000 respectively. Bonus and Commissions will be
paid pursuant to such terms and conditions as are established by the CEO, subject to approval
by the Committee, and, to the extent payable under a Bonus and Commission Plan, subject to
such terms and conditions as may be set out in such plans. The annual Bonus and/or Commission
shall, if payable, be paid no later than during the second quarter of the fiscal year
following the fiscal year for which such Bonus and Commissions are paid, unless otherwise
provided in the applicable Bonus and Commission Plans or written action taken by the CEO.
	 
	3.	 	Benefits. Executive shall participate in the Parent’s benefit plans on the same terms and
conditions as provided for other Parent executives, and subject to all terms and conditions of
such plans.
	 
	4.	 	Stock Grant. As of the Effective Date, Executive shall be issued 10,000 newly issued shares
of common stock of the Parent for $100 in cash (i.e., par value) as an inducement to Executive
to enter into this Agreement. Such shares shall be “restricted” securities within the meaning
of Rule 144 promulgated under the Securities Act of 1933 and shall not otherwise be
restricted.
	 
	5.	 	Stock Option Grants. A grant of incentive stock options, for 200,000 shares of common
stock, shall be made on the Effective Date, with an option exercise price equal to the greater
of $2.00 per share or the fair market value of a share, determined as of the date of grant,
and subject to vesting in thirty six substantially equal monthly installments during the first
three years of employment. The stock options will be granted under an inducement grant with
terms as nearly as practicable identical to the terms and conditions of the Parent’s 2005
Incentive Compensation Plan.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]